Health
Regeneron COVID-19 drug trial halted in sickest patients – Fox Business
Suspension is due to safety concern; testing continues in patients with less serious cases
Regeneron Pharmaceuticals Inc. suspended testing of its Covid-19 antibody drug in the sickest hospitalized patients because of a safety concern, the latest setback for antibody-drug trials in patients with the most advanced disease.
Regeneron said Friday it is pausing enrollment of hospitalized Covid-19 patients receiving mechanical ventilation or high-flow oxygen, after an independent monitoring committee observed a potential safety signal and an unfavorable risk/benefit profile at this time.
The…
-
Noosa News16 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News22 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business21 hours agoAre BHP shares are buy after its results?
-
Noosa News9 hours agoItalian Film Festival, Brisbane: All the Details